NFlection Therapeutics
Boston
About NFlection Therapeutics
NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases. It primarily addresses the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $41.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2022)
- Website: nflectionrx.com
- Phone: (617) 546-7606
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nflection-therapeutics-71597 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.